Healthcare, Resource Efficiency and Technology investors using digital and operational change to transform sustainable businesses and their value
US$3.7bn
Capital Deployed
40+ years
Investing Experience
Active Value Creation
In partnership with our management teams, we combine operational change with introducing artificial intelligence and automation to drive value in each of our investments
Stanley Capital’s involvement in Noden Pharma has reinvigorated our business through unparalleled rigour in the development of our value creation plans, the value-add board of directors they have built around the business and have helped develop an origination approach to our platform M&A strategy not seen in any other investment firm
Alan Markey, CEO – Noden Pharma
